Variant report

Variant	esv3356500
Chromosome Location	chr4:82134953-82137501
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:65)
CpG islands
(count:488)
Chromatin interactive
region (count:0)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:65 , 50 per page) page: 1 2

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BACH1	chr4:82135714-82136430	H1-hESC	embryonic stem cell:	n/a	n/a
2	CTBP2	chr4:82135495-82136857	H1-hESC	embryonic stem cell:	n/a	n/a
3	CTCF	chr4:82136880-82137030	NHDF-neo	bronchial:	n/a	n/a
4	CTCF	chr4:82136320-82136470	AG09319	gingival:	n/a	n/a
5	CTCF	chr4:82137080-82137230	NHDF-neo	bronchial:	n/a	n/a
6	CTCF	chr4:82137220-82137370	HCM	heart:	n/a	chr4:82137293-82137314
7	CTCF	chr4:82137160-82137310	AG04450	lung:	n/a	n/a
8	CTCF	chr4:82137200-82137350	HMF	breast:	n/a	chr4:82137293-82137314
9	CTCF	chr4:82137280-82137430	NHLF	lung:	n/a	chr4:82137293-82137314
10	CTCF	chr4:82136375-82136389	H1-hESC	embryonic stem cell:	n/a	n/a
11	CTCF	chr4:82136848-82136897	Fibrobl	skin:	n/a	n/a
12	CTCF	chr4:82137264-82137343	LNCaP	prostate:	n/a	chr4:82137293-82137314
13	CTCF	chr4:82137140-82137290	AG09319	gingival:	n/a	n/a
14	CTCF	chr4:82137300-82137450	AG04450	lung:	n/a	n/a
15	CTCF	chr4:82137060-82137210	HAc	cerebellar:	n/a	n/a
16	CTCF	chr4:82136292-82136395	Fibrobl	skin:	n/a	n/a
17	CTCF	chr4:82137200-82137350	RPTEC	kidney:	n/a	chr4:82137293-82137314
18	CTCF	chr4:82137160-82137310	AG04449	skin:	n/a	n/a
19	CTCF	chr4:82137280-82137430	BJ	skin:	n/a	chr4:82137293-82137314
20	CTCF	chr4:82137220-82137370	HBMEC	blood vessel:	n/a	chr4:82137293-82137314
21	CTCF	chr4:82137180-82137330	HRE	kidney:	n/a	chr4:82137293-82137314
22	CTCF	chr4:82137160-82137310	HRPEpiC	eye:	n/a	n/a
23	CTCF	chr4:82137140-82137290	NHDF-neo	bronchial:	n/a	n/a
24	CTCF	chr4:82137200-82137350	AG09319	gingival:	n/a	chr4:82137293-82137314
25	CTCF	chr4:82137268-82137328	Medullo	brain:	n/a	chr4:82137293-82137314
26	CTCF	chr4:82137240-82137390	HPF	lung:	n/a	chr4:82137293-82137314
27	CTCF	chr4:82137180-82137330	HPF	lung:	n/a	chr4:82137293-82137314
28	CTCF	chr4:82136260-82136410	HMEC	breast:	n/a	n/a
29	CTCF	chr4:82137220-82137370	HMF	breast:	n/a	chr4:82137293-82137314
30	CTCF	chr4:82136900-82137050	HPF	lung:	n/a	n/a
31	CTCF	chr4:82137269-82137318	LNCaP	prostate:	n/a	chr4:82137293-82137314
32	CTCF	chr4:82135500-82135650	WI-38	lung:	n/a	n/a
33	CTCF	chr4:82137180-82137330	HCPEpiC	choroid plexus:	n/a	chr4:82137293-82137314
34	CTCF	chr4:82137220-82137370	HPAF	blood vessel:	n/a	chr4:82137293-82137314
35	CTCF	chr4:82135916-82135939	Fibrobl	skin:	n/a	n/a
36	E2F6	chr4:82135595-82137178	H1-hESC	embryonic stem cell:	n/a	chr4:82135828-82135840 chr4:82136488-82136497 chr4:82136296-82136305
37	E2F6	chr4:82135758-82137090	H1-hESC	embryonic stem cell:	n/a	chr4:82135828-82135840 chr4:82136488-82136497 chr4:82136296-82136305
38	FOXP2	chr4:82136070-82136528	PFSK-1	brain:	n/a	n/a
39	JUN	chr4:82135586-82135809	H1-hESC	embryonic stem cell:	n/a	n/a
40	KAP1	chr4:82135390-82136244	HEK293	kidney:	n/a	n/a
41	MAFK	chr4:82135367-82135463	HepG2	liver:	n/a	n/a
42	MAX	chr4:82136544-82137147	H1-hESC	embryonic stem cell:	n/a	n/a
43	MAX	chr4:82135603-82136512	H1-hESC	embryonic stem cell:	n/a	n/a
44	MAX	chr4:82136531-82137083	H1-hESC	embryonic stem cell:	n/a	n/a
45	MAX	chr4:82135663-82136462	H1-hESC	embryonic stem cell:	n/a	n/a
46	MAX	chr4:82136242-82137085	H1-hESC	embryonic stem cell:	n/a	n/a
47	MAX	chr4:82136604-82137041	A549	lung:	n/a	n/a
48	MAZ	chr4:82135879-82137030	IMR90	lung:	n/a	n/a
49	MXI1	chr4:82136622-82136940	H1-hESC	embryonic stem cell:	n/a	n/a
50	MYC	chr4:82136642-82136722	H1-hESC	embryonic stem cell:	n/a	n/a

(count:488 , 50 per page) page: 1 2 3 4 5 6 7 ... 10

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr4:82136489-82136539	ProgFib	skin:	n/a
2	chr4:82136489-82136539	AoSMC	blood vessel:	n/a
3	chr4:82136839-82136889	NB4	blood:	n/a
4	chr4:82135784-82135834	HL-60	blood:	n/a
5	chr4:82136489-82136539	HPAEpiC	pulmonary alveolar:	n/a
6	chr4:82136489-82136539	NB4	blood:	n/a
7	chr4:82136940-82136990	ovcar-3	ovarian:	n/a
8	chr4:82135987-82136037	MCF-7	breast:	n/a
9	chr4:82135784-82135834	HCT-116	colon:	n/a
10	chr4:82136940-82136990	SAEC	small airway:	n/a
11	chr4:82136940-82136990	T-47D	breast:	n/a
12	chr4:82136823-82136873	Caco-2	colon:	n/a
13	chr4:82136116-82136166	NHDF-neo	bronchial:	n/a
14	chr4:82136940-82136990	AG04450	lung:	fetal
15	chr4:82135987-82136037	LNCaP	prostate:	n/a
16	chr4:82135987-82136037	HAEpiC	amniotic membrane:	n/a
17	chr4:82136823-82136873	MCF10A-Er-Src	breast:	n/a
18	chr4:82136116-82136166	PANC-1	pancreas:	n/a
19	chr4:82135784-82135834	HRE	kidney:	n/a
20	chr4:82136116-82136166	GM06990	blood:	n/a
21	chr4:82136489-82136539	GM12892	blood:	n/a
22	chr4:82135607-82135657	HMEC	breast:	n/a
23	chr4:82135607-82135657	PANC-1	pancreas:	n/a
24	chr4:82136839-82136889	HIPEpiC	eye:	n/a
25	chr4:82136116-82136166	PFSK-1	brain:	n/a
26	chr4:82135607-82135657	PrEC	prostate:	n/a
27	chr4:82136489-82136539	H1-hESC	embryonic stem cell:	embryo
28	chr4:82136116-82136166	HMEC	breast:	n/a
29	chr4:82135784-82135834	HCF	heart:	n/a
30	chr4:82136116-82136166	CMK	blood:	n/a
31	chr4:82136940-82136990	SK-N-SH_RA	brain:	n/a
32	chr4:82136823-82136873	AG04449	skin:	fetal
33	chr4:82135784-82135834	GM12878	blood:	n/a
34	chr4:82136823-82136873	GM12892	blood:	n/a
35	chr4:82136116-82136166	IMR90	lung:	fetal
36	chr4:82136823-82136873	Jurkat	blood:	n/a
37	chr4:82136489-82136539	HepG2	liver:	n/a
38	chr4:82136823-82136873	HRE	kidney:	n/a
39	chr4:82136940-82136990	HCPEpiC	choroid plexus:	n/a
40	chr4:82135607-82135657	MCF10A-Er-Src	breast:	n/a
41	chr4:82136940-82136990	AoSMC	blood vessel:	n/a
42	chr4:82135987-82136037	HEK293	kidney:	embryo
43	chr4:82136489-82136539	SK-N-MC	brain:	n/a
44	chr4:82135784-82135834	GM12892	blood:	n/a
45	chr4:82136940-82136990	Jurkat	blood:	n/a
46	chr4:82136823-82136873	AG10803	skin:	n/a
47	chr4:82135987-82136037	HL-60	blood:	n/a
48	chr4:82135987-82136037	HEEpiC	esophagus:	n/a
49	chr4:82135987-82136037	T-47D	breast:	n/a
50	chr4:82136940-82136990	LNCaP	prostate:	n/a

No data

Variant related genes	Relation type
PRKG2	TF binding region
PRKG2	CpG island

Extended variants
information (count: 72 )
Associated
traits (count: 77 )

Variant overlapped rSNPs/rCNVs (count:72 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs186773756	chr4:82135029-82135030	Active TSS Enhancers Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
2	rs551108999	chr4:82135050-82135051	Active TSS Enhancers Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
3	rs555637884	chr4:82135056-82135057	Active TSS Enhancers Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
4	rs7691253	chr4:82135079-82135080	Active TSS Enhancers Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
5	rs111974946	chr4:82135090-82135091	Active TSS Enhancers Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
6	rs556921772	chr4:82135105-82135106	Active TSS Enhancers Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
7	rs567126131	chr4:82135189-82135190	Active TSS Enhancers Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
8	rs710840	chr4:82135230-82135231	Active TSS Flanking Active TSS Enhancers Bivalent/Poised TSS Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
9	rs553285730	chr4:82135258-82135259	Active TSS Flanking Active TSS Enhancers Bivalent/Poised TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
10	rs528946550	chr4:82135280-82135281	Active TSS Flanking Active TSS Enhancers Bivalent/Poised TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
11	rs573100790	chr4:82135282-82135283	Active TSS Flanking Active TSS Enhancers Bivalent/Poised TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
12	rs191204519	chr4:82135292-82135293	Active TSS Flanking Active TSS Enhancers Bivalent/Poised TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
13	rs11355853	chr4:82135308-82135309	Active TSS Flanking Active TSS Enhancers Bivalent/Poised TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
14	rs79889157	chr4:82135323-82135324	Active TSS Flanking Active TSS Enhancers Bivalent/Poised TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
15	rs75674338	chr4:82135334-82135335	Active TSS Flanking Active TSS Enhancers Bivalent/Poised TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
16	rs34749329	chr4:82135350-82135351	Active TSS Flanking Active TSS Enhancers Bivalent/Poised TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
17	rs577941932	chr4:82135423-82135424	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs578055385	chr4:82135444-82135445	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs187950142	chr4:82135511-82135512	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs375203314	chr4:82135586-82135587	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs376200013	chr4:82135593-82135594	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs563722536	chr4:82135607-82135608	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
23	rs573683663	chr4:82135628-82135629	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
24	rs542942136	chr4:82135746-82135747	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
25	rs34293944	chr4:82135822-82135823	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs559617561	chr4:82135833-82135834	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs528702894	chr4:82135849-82135850	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs551963141	chr4:82135895-82135896	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs565291975	chr4:82135910-82135911	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs530655016	chr4:82135950-82135951	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs550373349	chr4:82135976-82135977	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs548714018	chr4:82135977-82135978	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs149205027	chr4:82135995-82135996	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs536229885	chr4:82136024-82136025	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs192836977	chr4:82136132-82136133	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs566760920	chr4:82136173-82136174	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs805792	chr4:82136187-82136188	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs538893537	chr4:82136211-82136212	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
39	rs558718685	chr4:82136228-82136229	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
40	rs575318290	chr4:82136229-82136230	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
41	rs537567747	chr4:82136287-82136288	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
42	rs557153598	chr4:82136288-82136289	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
43	rs558879170	chr4:82136316-82136317	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
44	rs368058210	chr4:82136386-82136387	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
45	rs542604635	chr4:82136426-82136427	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
46	rs559283643	chr4:82136468-82136469	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
47	rs788862	chr4:82136500-82136501	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	TF binding region CpG island	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
48	rs143351563	chr4:82136525-82136526	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
49	rs565494305	chr4:82136531-82136532	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
50	rs201857833	chr4:82136566-82136567	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:77)

Disease	PMID	Source
Acute lymphoblastic leukemia	22237106	CNVD
Glioblastoma multiforme	21080181	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Chordoma	21602918	CNVD
HIV/AIDS	22032296	CNVD
Medulloblastoma	21979893	CNVD
Neuroblastoma	18923191	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Intellectual disability	22102821	CNVD
Autism	22495311	CNVD
Breast cancer	21858162	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Gastric cancer	21586687	CNVD
lymphocytic leukemia	21291569	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Melanoma	18172304	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Breast cancer	17603634	CNVD
Glioblastoma multiforme	21922591	CNVD
Parkinson disease	21956041	CNVD
Mental retardation	20522426	CNVD
delayed speech	20522426	CNVD
growth disorder	20522426	CNVD
Hepatocellular carcinoma	16750200	CNVD
Myxofibrosarcoma	16751306	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Parkinson disease	18923514	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Cancer	21183584	CNVD
Breast cancer	16272173	CNVD
Colorectal cancer	19359472	CNVD
Malignant mesothelioma	18160781	CNVD
Medulloblastoma	18056178	CNVD
Multiple myeloma	17077331	CNVD
Pleural malignant mesothelioma	18160781	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Oral squamous cell carcinoma	17134496	CNVD
4q-syndrome	17576883	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Colorectal cancer	20709793	CNVD
Muscular dystrophy	21149563	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Hepatocellular carcinoma	22174799	CNVD
Liposarcoma	21253554	CNVD
Oligodendroglial tumors	17285580	CNVD
Cervical cancer	21062161	CNVD
Metanephric adenoma	20802469	CNVD
Breast cancer	16608533	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Lung cancer	19208797	CNVD
Wilms tumour	21544195	CNVD
Breast cancer	21785460	CNVD
Basal cell lymphoma	17170743	CNVD
Follicular lymphoma	17170743	CNVD
Chronic lymphocytic leukemia	20421269	CNVD
Myelodysplastic syndrome	21251322	CNVD
Multiple myeloma	17550852	CNVD
small cell lung cancer	20016488	CNVD
Lung cancer	18438408	CNVD
Chronic lymphocytic leukemia	18922857	CNVD
Cancer	22429812	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Autism	18414403	CNVD
Chronic lymphocytic leukemia	21670202	CNVD
primary effusion lymphomas	17116491	CNVD
Gastric cancer	16891809	CNVD
Prostate cancer	16573809	CNVD
Myelofibrosis	22110671	CNVD
Neuroblastoma	21899760	CNVD
Myelodysplastic syndrome	18508791	CNVD
abnormal development	18461090	CNVD

Chromatin state (count:280 , 50 per page) page: 1 2 3 4 5 6

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr4:82132000-82135000	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
2	chr4:82132200-82136200	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
3	chr4:82132800-82135400	Active TSS	Fetal Intestine Large	intestine
4	chr4:82133200-82136000	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Female	--
5	chr4:82133600-82135200	Active TSS	Fetal Intestine Small	intestine
6	chr4:82134200-82135400	Bivalent/Poised TSS	Primary T cells from cord blood	blood
7	chr4:82134200-82136600	Active TSS	NHDF-Ad	bronchial
8	chr4:82134400-82137200	Active TSS	NHLF	lung
9	chr4:82134600-82135000	Flanking Active TSS	Foreskin Fibroblast Primary Cells skin02	Skin
10	chr4:82134600-82135000	Flanking Active TSS	Fetal Brain Female	brain
11	chr4:82134600-82135200	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
12	chr4:82134600-82135800	Bivalent/Poised TSS	Fetal Brain Male	brain
13	chr4:82134600-82137000	Bivalent/Poised TSS	Duodenum Smooth Muscle	Duodenum
14	chr4:82134800-82135400	Bivalent Enhancer	Primary hematopoietic stem cells	blood
15	chr4:82134800-82135600	Bivalent Enhancer	Foreskin Melanocyte Primary Cells skin01	Skin
16	chr4:82134800-82135800	Active TSS	Foreskin Fibroblast Primary Cells skin01	Skin
17	chr4:82134800-82136400	Active TSS	IMR90 fetal lung fibroblasts Cell Line	lung
18	chr4:82134800-82136800	Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
19	chr4:82135000-82135200	Active TSS	Brain Inferior Temporal Lobe	brain
20	chr4:82135000-82135200	Active TSS	Fetal Brain Female	brain
21	chr4:82135000-82135600	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
22	chr4:82135000-82135600	Bivalent/Poised TSS	Brain Cingulate Gyrus	brain
23	chr4:82135000-82135600	Bivalent Enhancer	Brain Hippocampus Middle	brain
24	chr4:82135000-82136800	Active TSS	Foreskin Fibroblast Primary Cells skin02	Skin
25	chr4:82135200-82135400	Bivalent Enhancer	Foreskin Melanocyte Primary Cells skin03	Skin
26	chr4:82135200-82135400	Bivalent Enhancer	Rectal Mucosa Donor 31	rectum
27	chr4:82135200-82135600	Flanking Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
28	chr4:82135200-82135600	Flanking Active TSS	Fetal Brain Female	brain
29	chr4:82135200-82136400	Bivalent/Poised TSS	Rectal Mucosa Donor 29	rectum
30	chr4:82135200-82136600	Bivalent/Poised TSS	Fetal Intestine Small	intestine
31	chr4:82135200-82137200	Bivalent/Poised TSS	Brain Inferior Temporal Lobe	brain
32	chr4:82135200-82137200	Active TSS	Rectal Smooth Muscle	rectum
33	chr4:82135400-82135600	Bivalent Enhancer	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
34	chr4:82135400-82135600	Bivalent Enhancer	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
35	chr4:82135400-82135600	Flanking Bivalent TSS/Enh	HUES64 Cell Line	embryonic stem cell
36	chr4:82135400-82135600	Flanking Bivalent TSS/Enh	iPS-15b Cell Line	embryonic stem cell
37	chr4:82135400-82135600	Flanking Bivalent TSS/Enh	iPS-18 Cell Line	embryonic stem cell
38	chr4:82135400-82135600	Bivalent Enhancer	Breast Myoepithelial Primary Cells	Breast
39	chr4:82135400-82135600	Flanking Bivalent TSS/Enh	Primary hematopoietic stem cells	blood
40	chr4:82135400-82135600	Flanking Bivalent TSS/Enh	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
41	chr4:82135400-82135600	Bivalent Enhancer	Foreskin Keratinocyte Primary Cells skin02	Skin
42	chr4:82135400-82135600	Bivalent/Poised TSS	Adipose Nuclei	Adipose
43	chr4:82135400-82135600	Enhancers	Colon Smooth Muscle	Colon
44	chr4:82135400-82135600	Bivalent Enhancer	Fetal Lung	lung
45	chr4:82135400-82135600	Bivalent Enhancer	Fetal Stomach	stomach
46	chr4:82135400-82135600	Bivalent Enhancer	Skeletal Muscle Female	skeletal muscle
47	chr4:82135400-82135800	Active TSS	Colonic Mucosa	Colon
48	chr4:82135400-82135800	Active TSS	Lung	lung
49	chr4:82135400-82136000	Bivalent/Poised TSS	Fetal Intestine Large	intestine
50	chr4:82135400-82136000	Flanking Bivalent TSS/Enh	Rectal Mucosa Donor 31	rectum

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links